Protecting Your Rights: Shareholder Actions for RBGLY

Author: Dylan Bailey Updated: 07-31-2025 08:57 AM

Important Information for Shareholders of Reckitt Benckiser Group plc

The Gross Law Firm issues a crucial notice for shareholders of Reckitt Benckiser Group plc (RBGLY). Shareholders who purchased shares during the class period are urged to contact the firm to discuss potential lead plaintiff appointments. You do not need to be appointed as a lead plaintiff to be involved in any recovery related to this case.

Understanding the Class Period

The class period for this action spans from January 13, 2021, to July 28, 2024. This timeframe marks the period when shareholders may have experienced losses due to the issues surrounding the company.

Allegations Against Reckitt Benckiser

The complaint brought against Reckitt Benckiser alleges that the company made materially false and misleading statements regarding the safety of its products, particularly its cow's milk-based formula, Enfamil. Preterm infants consuming this formula were reportedly at increased risk of developing necrotizing enterocolitis (NEC), a serious intestinal condition. The case highlights the lack of transparency regarding the potential dangers and the subsequent impact on Reckitt's sales and involvement in legal matters.

Upcoming Deadline for Shareholders

Shareholders are advised of an important deadline on August 4, 2025, by which time they must take action to ensure their rights are protected in this class action lawsuit. Delaying registration for this action could limit the ability to recover losses incurred during the class period.

Next Steps for Shareholders

After registering as a shareholder who purchased shares of RBGLY during the specified timeframe, individuals will be enrolled in a portfolio monitoring program. This program will keep investors informed of developments and updates regarding the case. Importantly, there is no fee to participate, ensuring all interested shareholders can be involved without financial pressure.

Why Choose The Gross Law Firm?

The Gross Law Firm is a respected name in class action law, dedicated to protecting the rights of investors against fraudulent business practices. They strive to ensure that corporations adhere to high standards of ethical conduct and corporate responsibility. Their commitment to justice helps investors recover losses resulting from misleading statements that artificially inflate stock prices.

Contact Information

For more information or to get in touch, contact The Gross Law Firm at:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY 10018
Email: dg@securitiesclasslaw.com
Phone: (646) 453-8903

Frequently Asked Questions

What is the deadline for shareholders to act?

The deadline for shareholders to take action is August 4, 2025.

What is the class period for the lawsuit?

The class period runs from January 13, 2021, to July 28, 2024.

What allegations are being made against Reckitt Benckiser?

The allegations include that Reckitt Benckiser misled shareholders about the safety of its Enfamil formula, associated with serious health risks for infants.

Do I need to be a lead plaintiff to participate?

No, being a lead plaintiff is not necessary to partake in any recovery related to the lawsuit.

How can I get updates about the case?

By registering as a shareholder, you will be enrolled in a portfolio monitoring program to receive updates.

About The Author

My name is Dylan Bailey, and I am 28 years old. I am an author and an expert on the stock market who specializes in publicly traded companies. Early fascination with the stock market inspired me to seek a finance degree and then delve deeply into the world of stocks. I have developed over the years my abilities to spot investment prospects, assess business performance, and analyze market trends.

My books and articles try to help regular investors understand the nuances of the stock market. Anyone can, in my opinion, make wise investment choices and succeed financially if they have the correct information and resources. In my writing, I combine in-depth research with practical insights and advice that can be put into action. This is done with the intention of assisting readers in navigating the constantly shifting landscape of publicly traded companies.

In addition to writing, I also host webinars and workshops, where I give presentations and share my knowledge with a wider audience. I also write for top financial journals and show up as a guest analyst on financial news shows. I like to travel, spend time with my family, and keep active by playing different sports when I'm not buried in market research.

My goal is to enable people to choose wisely and consciously in their investments, so taking charge of their financial futures. By my work, I hope to create a community of informed and self-assured investors prepared to take advantage of the chances presented by the stock market.

Contact Dylan Bailey privately here. Or send an email with ATTN: Dylan Bailey as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.